CELLECT BIOTECHNOLOGY LTD (APOPW)
Institutional ownership reported to the SEC as of Q2 2021, across 11 quarters.
1
Reporting holders
$13.0K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| UBS Group AG | $13.0K | 62,507 | 0.00% | 3q | +2094.8%+$12.4K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2021 | 1 | $13.0K | 62,507 | 0 | 1 | 0 | 0.0% |
| Q1 2021 | 1 | $1.0K | 2,848 | 0 | 0 | 1 | 0.0% |
| Q4 2020 | 2 | $11.0K | 61,250 | 1 | 1 | 0 | 0.0% |
| Q3 2020 | 1 | $2.0K | 19,760 | 1 | 0 | 0 | 0.0% |
| Q2 2020 | 1 | $1.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q1 2020 | 2 | $2.0K | 16,474 | 0 | 0 | 1 | 50.0% |
| Q4 2019 | 2 | $2.0K | 18,554 | 1 | 0 | 0 | 50.0% |
| Q3 2019 | 1 | $1.0K | 0 | 1 | 0 | 0 | 100.0% |
| Q2 2019 | 2 | $6.0K | 90,279 | 0 | 2 | 0 | 0.0% |
| Q1 2019 | 3 | $4.0K | 29,899 | 0 | 0 | 1 | 25.0% |
| Q4 2018 | 3 | $17.0K | 32,206 | 0 | 0 | 0 | 35.3% |